Novartis AG
Biaryl amide compounds as kinase inhibitors

Abstract:

The present invention provides compounds of Formula (I) ##STR00001## as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.